AMANDA CHANDLER: Open Payments
NPI 1750069449 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 97 payments from 12 companies in 2025. Trend: 2023 $525 · 2024 $973 · 2025 $1,739
Food & beverage: $1,739
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $663 |
| Gilead Sciences, Inc. | 12 | $287 |
| Madrigal Pharmaceuticals | 10 | $262 |
| Janssen Biotech, Inc. | 15 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| Ardelyx, Inc. | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $38 |
| United Therapeutics Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, SKYRIZI, Livdelzi, LINZESS, ENTYVIO, CREON.
Industry payments across AL — which companies pay providers there.
